Utility of current obesity thresholds in signaling diabetes risk in the james bay cree of Eeyou Istchee

BMJ Open Diabetes Research and Care

Volumn 3, Issue 1, 2015, Pages

  Manjoo, Priya ^a   Dannenbaum, David ^b,c   Joseph, Lawrence ^b   Torrie, Jill ^c   Dasgupta, Kaberi ^b  

^a UNIVERSITY OF VICTORIA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Cree Board of Health and Social Services of James Bay   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; BODY MASS; CANADA; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; HOMEOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WORLD HEALTH ORGANIZATION;

EID: 85027091406     PISSN: None     EISSN: 20524897     Source Type: Journal    
DOI: 10.1136/bmjdrc-2015-000114     Document Type: Article

References (36)

1. Lucero AA, Lambrick DM, Faulkner JA, et al. Modifiable cardiovascular disease risk factors among indigenous populations. Adv Prev Med 2014;2014:547018.
2. Sui X, Hooker SP, Lee IM, et al. A prospective study of cardiorespiratory fitness and risk of type 2 diabetes in women. Diabetes Care 2008;31:550-5.
3. [No authors listed]. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1-452.
4. Lear SA, Toma M, Birmingham CL, et al. Modification of the relationship between simple anthropometric indices and risk factors by ethnic background. Metabolism 2003;52:1295-301.
5. Lear SA, Chen MM, Frohlich JJ, et al. The relationship between waist circumference and metabolic risk factors: cohorts of European and Chinese descent. Metabolism 2002;51:1427-32.
6. Razak F, Anand S, Vuksan V, et al. Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes (Lond) 2005;29:656-67.
7. Razak F, Anand SS, Shannon H, et al. Defining obesity cut points in a multiethnic population. Circulation 2007;115:2111-18.
8. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-63.
9. Jensen MD. Adipose tissue and fatty acid metabolism in humans. J R Soc Med 2002;95(Suppl 42):3-7.
10. Pouliot MC, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-8.
11. Han TS, van Leer EM, Seidell JC, et al. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 1995;311:1401-5.
12. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995;311:158-61.
13. Langenberg C, Sharp SJ, Schulze MB, et al. Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study. PLoS Med 2012;9: e1001230.
14. Qiao Q, Nyamdorj R. The optimal cutoff values and their performance of waist circumference and waist-to-hip ratio for diagnosing type II diabetes. Eur J Clin Nutr 2010;64:23-9.
15. Bodicoat DH, Gray LJ, Henson J, et al. Body mass index and waist circumference cut-points in multi-ethnic populations from the UK and India: the ADDITION-Leicester, Jaipur heart watch and New Delhi cross-sectional studies. PLoS ONE 2014;9:e90813.
16. Li M, McDermott RA. Using anthropometric indices to predict cardio-metabolic risk factors in Australian indigenous populations. Diabetes Res Clin Pract 2010;87:401-6.
17. The IDF consensus worldwide definition of the metabolic syndrome. [article online]. 2006.
18. Commission of Canada. Truth and Reconciliation. 2015.
19. Gast KB, Tjeerdema N, Stijnen T, et al. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS ONE 2012;7:e52036.
20. Egeland GM, Denomme D, Lejeune P, et al. Concurrent validity of the International Physical Activity Questionnaire (IPAQ) in an liyiyiu Aschii (Cree) community. Can J Public Health 2008;99:307-10.
21. Johnson-Down L, Labonte ME, Martin ID, et al. Quality of diet is associated with insulin resistance in the Cree (Eeyouch) indigenous population of northern Quebec. Nutr Metab Cardiovasc Dis 2015;25:85-92.
22. Johnson-Down LM, Egeland GM. How is nutrition transition affecting dietary adequacy in Eeyouch (Cree) adults of Northern Quebec, Canada? Appl Physiol Nutr Metab 2013;38:300-5.
23. Albareda M, Rodriguez-Espinosa J, Murugo M, et al. Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 2000;43:1507-11.
24. Bonora E, Formentini G, Calcaterra F, et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 2002;25:1135-41.
25. Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord 2013;13:47.
26. Goldenberg R, Punthakee Z. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes 2013;37(Suppl 1):S8-11.
27. Guyatt G, Rennie D, Meade M, et al. Users ' guides to the medical literature: a manual for evidence-based clinical practice. 2nd edn. McGraw-Hill Professional, 2008.
28. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978;8:283-98.
29. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
30. Lear SA, Humphries KH, Frohlich JJ, et al. Appropriateness of current thresholds for obesity-related measures among Aboriginal people. CMAJ 2007;177:1499-505.
31. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-95.
32. Hermans MP, Levy JC, Morris RJ, et al. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 1999;42:678-87.
33. Tuomilehto J, Lindstrõm J, Eriksson J, et al. for the Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.
34. Knowler W, Barrett-Connor E, Fowler S, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
35. Ramachandran A, Snehalatha C, Mary S, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289-97.
36. Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 2005;67:152-62.